Treace Medical Concepts (TMCI) Share-based Compensation (2020 - 2026)

Treace Medical Concepts' Share-based Compensation history runs 7 years deep, the most recent figure standing at $8.0 million for Q1 2026.

• Quarterly Share-based Compensation fell 7.58% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $243000.0 (down 99.24% YoY) and the FY2025 annual result came in at $4.1 million, down 86.6% from the prior year.
• Share-based Compensation was $8.0 million for Q1 2026 at Treace Medical Concepts, up from -$25.4 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $9.6 million in Q2 2025 and bottomed at -$25.4 million in Q4 2025.
• A 5-year average of $3.8 million and a median of $5.9 million in 2023 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation jumped 250.5% — and 2025, when it slumped 396.5%.
• Treace Medical Concepts' Share-based Compensation stood at $2.5 million in 2022, then jumped by 138.18% to $5.9 million in 2023, then jumped by 45.42% to $8.6 million in 2024, then sank by 396.5% to -$25.4 million in 2025, then soared by 131.67% to $8.0 million in 2026.
• Business Quant data shows TMCI's Share-based Compensation at $8.0 million in Q1 2026, -$25.4 million in Q4 2025, and $8.0 million in Q3 2025.